A-6 | Outcomes of ST Elevation Myocardial Infarction in Young Patients with Stimulant Use

Stimulant drug use causes a variety of acute & chronic cardiovascular toxicities, with ACS being the most common acute presentation. Most stimulant-associated MI tend to have normal coronaries. We aim to compare STEMI outcomes in stimulant users & non-users. The national readmission database (2016-2020) was utilized to identify hospitalizations for STEMI in patients aged 0.05). Stimulant users were found to have lower utilization of PCA (81.3% vs 84.4%), PCI (55.1% vs 65.7%), and drug-eluting stent (DES) placement (45.9% vs 59.7%) but higher rates of a bare metal stent (BMS) or angioplasty (12.2% vs 6.5%) p0.05). Female gender (aOR: 1.41), DM (aOR: 1.4), CKD (aOR: 1.62) & HF (aOR:1.6) were found to be significant predictors of readmission [p<0.001. In STEMI hospitalizations, stimulant users have higher mortality and readmission rates and lower rates of revascularizations.